← FDA Drug Approvals (Drugs@FDA)
CARMUSTINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2023-03-03
Drug application
- FDA Application #
ANDA215368- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CARMUSTINE
- Generic name
- Carmustine
- Active ingredients
- CARMUSTINE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- PHARMOBEDIENT
- First approval
- 2023-03-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown